[CAS NO. 55497-79-5]  Myriceric acid B

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [55497-79-5]

Catalog
HY-N3222
Brand
MCE
CAS
55497-79-5

DESCRIPTION [55497-79-5]

Overview

MDL-
Molecular Weight634.84
Molecular FormulaC39H54O7
SMILESOC1=C(O)C=CC(/C=C/C(OC[C@]23[C@@]4(C)[C@@](CC=C2[C@@]5([H])[C@](C(O)=O)(CCC(C)(C)C5)CC3)([H])[C@@]6([C@@](C(C)([C@@H](O)CC6)C)([H])CC4)C)=O)=C1

For research use only. We do not sell to patients.

Summary

Myriceric acid B is a potent HIV-1 entry inhibitor targeting gp41. Myriceric acid B is an antitumor agent [1] [2] .


IC50 & Target

HIV-1

8.3±0.2 μg/mL (IC 50 , infection of HIV-1 Env pseudovirus)


In Vitro

Myriceric acid B (0-30 μM; 72 h) shows potent cytotoxicity against tumor cells [1] .
Myriceric acid B significantly inhibits the infection of HIV-1 Env pseudovirus with an IC 50 of 8.3±0.2 mg/L [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay [1]

Cell Line: A549, SK-OV-3, SK-MEL-2 and Bt549
Concentration: 0-30 μM
Incubation Time: 72 h
Result: Exhibited potent cytotoxicity against all of the tumor cell lines tested, with IC 50 s of 5.7±0.3, 9.8±0.5, 6.0±0.7 and 5.8±0.4 μM against A549, SK-OV-3, SK-MEL-2 and Bt549, respectively.


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.